Eun-Ah Lee

Title: Eun-Ah Lee: Innovator in Antibody Development

Introduction

Eun-Ah Lee is a prominent inventor based in South Korea, recognized for her contributions to the field of biotechnology. She has focused her research on the development of antibodies that target specific receptors involved in blood vessel stabilization and normalization. Her work has significant implications for treating various angiogenesis-associated diseases.

Latest Patents

Eun-Ah Lee holds a patent titled "Anti-Tie2 Antibody And Use Thereof." This invention relates to an antibody that specifically binds to the tyrosine-protein kinase receptor TIE-2 (TIE2). The antibody possesses functions that promote blood vessel normalization and stabilization through receptor phosphorylation. The patent encompasses various components, including a nucleic acid encoding the antibody, a vector containing the nucleic acid, and a method for preparing the antibody. Additionally, it includes an agent for stabilizing blood vessels and a composition for treating diseases associated with angiogenesis.

Career Highlights

Throughout her career, Eun-Ah Lee has made significant strides in the field of antibody research. Her innovative approach to targeting TIE2 has opened new avenues for therapeutic interventions in cancer treatment and other related conditions. Despite having no patents listed under her name, her contributions to the scientific community are noteworthy.

Collaborations

Eun-Ah Lee has collaborated with esteemed colleagues, including Beom Yong Park and Nu Ri Kang. These partnerships have enhanced her research efforts and contributed to the advancement of her innovative projects.

Conclusion

Eun-Ah Lee is a dedicated inventor whose work in antibody development has the potential to transform treatments for angiogenesis-related diseases. Her innovative research continues to inspire advancements in biotechnology and medicine.